Skip to main content
Top

Current Fungal Infection Reports

Issue 3/2023

Content (9 Articles)

Can There Be a Relationship Between Oral Candidiasis and Candidemia in ICU Patients?

Dalviany Taques Ferreira, Priscila Vieira da Silva, Hélio Chagas Chaves de Oliveira Junior, Kellyth Andrade Pereira Rocha, Diego Romário da Silva, Nayla de Souza Pitangui, Janaina de Cássia Orlandi Sardi

Open Access Cystic Fibrosis

Respiratory Fungal Infections in Cystic Fibrosis: Diagnostic and Therapeutic Challenges

C. Schwarz, J. G. Mainz, E. Romanowska, S. Rosseau, H. Schuette, L. Martin-Souto, A. Ramirez-Garcia, P. Eschenhagen

Tinea Nigra in Children

Norma Olivia de la O-Escamilla, Dulce Melissa Martínez–Téllez, Miguel Ángel Sánchez-Romero, Elizabeth Esther Cortés-Salazar, Mirna Eréndira Toledo-Bahena, Carlos Alfredo Mena-Cedillos, Sonia Toussaint–Caire, Marcela Salazar–García, Adriana Valencia-Herrera, Alexandro Bonifaz

Onychomycosis Caused by Fusarium Species: a Review

Jorge Arturo Mayorga Rodríguez, Julio Roberto Hernández-Juárez, Eduardo Corona-Rodarte, Víctor Fernando Muñoz-Estrada

Diagnostic Efficacy of LAMP Assay for Human Fungal Pathogens: a Systematic Review and Meta-analysis

Gurvinder Singh Bumbrah, Sarika Jain, Shweta Singh, Zeeshan Fatima, Saif Hameed

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine